Differences in QOF CVD prescribing targetsa by serious mental illness status adjusted for sociodemographic characteristics and primary care consultation frequency
| Reference (non-SMI) | Unadjusted OR (95% CI) | Adjusted for sociodemographics ORb (95% CI) | Additionally adjusted for consultation rate ORc (95% CI) | |
|---|---|---|---|---|
| Beta blocker | ||||
| After CHD | 1.00 | 0.62 (0.41 to 0.93)d | 0.68 (0.44 to 1.05) | 0.66 (0.42 to 1.01) |
| After HF | 1.00 | 0.29 (0.16 to 0.53)f | 0.29 (0.15 to 0.55)f | 0.27 (0.14 to 0.52)f |
| ACEI/ARB | ||||
| After CHD | 1.00 | 0.59 (0.36 to 0.97)d | 0.55 (0.33 to 0.94)d | 0.47 (0.27 to 0.80)e |
| After HF | 1.00 | 0.33 (0.18 to 0.61)f | 0.34 (0.18 to 0.66)f | 0.31 (0.16 to 0.60)f |
| Antiplatelet/anticoagulant | ||||
| After CHD | 1.00 | 0.95 (0.54 to 1.65) | 1.04 (0.57 to 1.89) | 0.94 (0.51 to 1.73) |
| After STIA | 1.00 | 1.04 (0.68 to 1.60) | 0.99 (0.62 to 1.59) | 1.04 (0.64 to 1.69) |
| Statin | ||||
| After CHD | 1.00 | 0.76 (0.45 to 1.28) | 0.78 (0.45 to 1.36) | 0.70 (0.40 to 1.23) |
| Quadruple therapyg | ||||
| After CHD | 1.00 | 0.65 (0.40 to 1.06) | 0.62 (0.37 to 1.04) | 0.28 (0.34 to 0.98)d |
ACEI/ARB = angiotensin-converting enzyme inhibitor/angiotensin receptor blocker. CHD = coronary heart disease. CVD = cardiovascular disease. HF = heart failure. OR = odds ratio. QOF = Quality and Outcomes Framework. SMI = severe mental illness. STIA = stroke/ transient ischaemic attack.
↵a Refers to QOF guidelines 2012/13.17
↵b Adjusted for age (continuous), sex, ethnic group, and borough-level deprivation.
↵c Additionally adjusted for mean annual number of primary consultations.
↵d P <0.05.
↵e P <0.01.
↵f P <0.001.
↵g Quadruple therapy indicated in patients with history of myocardial infarction and includes statin, antiplatelet/anticoagulant, beta blocker, and ACEI/ARB medication.